AN IRISH BIOTECHNOLOGY company that failed to make the grade on Dragon’s Den has taken the wraps off a €1 million Middle Eastern distribution deal.
Dublin-based MedColl, which makes anti-aging supplements, signed the deal with Il Ittihad Drugs despite being turned down by dragons Gavin Duffy and Ramona Nichols.
Chief executive Roz Martin said that she had managed to refine and develop her export offering in only 4 and a half months. She was assisted by Enterprise Ireland and export accelerators Associated Marketing.
Martin said that she was “a little disappointed” not to receive funding from the Dragons, but continued:
Their decision will not hold us back as we are currently working closely with Enterprise Ireland in identifying venture capitalists who have the ability and funding to help us expand the company and grow our global exports.
MedColl is specifically designed for women in their 30s and 40s, as well as post-menopausal women.
To embed this post, copy the code below on your site
have your say